These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18071984)

  • 1. Proteomic analysis of gliomas.
    Whittle IR; Short DM; Deighton RF; Kerr LE; Smith C; McCulloch J
    Br J Neurosurg; 2007 Dec; 21(6):576-82. PubMed ID: 18071984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular classification and survival prediction in human gliomas based on proteome analysis.
    Iwadate Y; Sakaida T; Hiwasa T; Nagai Y; Ishikura H; Takiguchi M; Yamaura A
    Cancer Res; 2004 Apr; 64(7):2496-501. PubMed ID: 15059904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid tissue.
    Brown LM; Helmke SM; Hunsucker SW; Netea-Maier RT; Chiang SA; Heinz DE; Shroyer KR; Duncan MW; Haugen BR
    Mol Carcinog; 2006 Aug; 45(8):613-26. PubMed ID: 16788983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarker discovery: a proteomic approach for brain cancer profiling.
    Khalil AA
    Cancer Sci; 2007 Feb; 98(2):201-13. PubMed ID: 17233837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics of gliomas: initial biomarker discovery and evolution of technology.
    Kalinina J; Peng J; Ritchie JC; Van Meir EG
    Neuro Oncol; 2011 Sep; 13(9):926-42. PubMed ID: 21852429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue Proteome Analysis of Different Grades of Human Gliomas Provides Major Cues for Glioma Pathogenesis.
    Gollapalli K; Ghantasala S; Atak A; Rapole S; Moiyadi A; Epari S; Srivastava S
    OMICS; 2017 May; 21(5):275-284. PubMed ID: 28481733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
    Dahlrot RH
    Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifarious proteomic signatures and regional heterogeneity in glioblastomas.
    Park CK; Jung JH; Park SH; Jung HW; Cho BK
    J Neurooncol; 2009 Aug; 94(1):31-9. PubMed ID: 19219580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of tumor-related proteins by proteomic analysis of cerebrospinal fluid from patients with primary brain tumors.
    Zheng PP; Luider TM; Pieters R; Avezaat CJ; van den Bent MJ; Sillevis Smitt PA; Kros JM
    J Neuropathol Exp Neurol; 2003 Aug; 62(8):855-62. PubMed ID: 14503641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of potential plasma biomarkers for esophageal squamous cell carcinoma by a proteomic method.
    Zhao J; Fan YX; Yang Y; Liu DL; Wu K; Wen FB; Zhang CY; Zhu DY; Zhao S
    Int J Clin Exp Pathol; 2015; 8(2):1535-44. PubMed ID: 25973038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic identification of tumor biomarkers associated with primary gallbladder cancer.
    Huang HL; Yao HS; Wang Y; Wang WJ; Hu ZQ; Jin KZ
    World J Gastroenterol; 2014 May; 20(18):5511-8. PubMed ID: 24833881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic-based prognosis of brain tumor patients using direct-tissue matrix-assisted laser desorption ionization mass spectrometry.
    Schwartz SA; Weil RJ; Thompson RC; Shyr Y; Moore JH; Toms SA; Johnson MD; Caprioli RM
    Cancer Res; 2005 Sep; 65(17):7674-81. PubMed ID: 16140934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A unique four-hub protein cluster associates to glioblastoma progression.
    Simeone P; Trerotola M; Urbanella A; Lattanzio R; Ciavardelli D; Di Giuseppe F; Eleuterio E; Sulpizio M; Eusebi V; Pession A; Piantelli M; Alberti S
    PLoS One; 2014; 9(7):e103030. PubMed ID: 25050814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid Proteomic Profiling by MALDI-TOF Mass Spectrometry for Better Brain Tumor Classification.
    Petre G; Durand H; Pelletier L; Poulenard M; Nugue G; Ray PF; Rendu J; Coutton C; Berger F; Bidart M
    Proteomics Clin Appl; 2020 Sep; 14(5):e1900116. PubMed ID: 32198817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Search for a diagnostic/prognostic biomarker for the brain cancer glioblastoma multiforme by 2D-DIGE-MS technique.
    Banerjee HN; Mahaffey K; Riddick E; Banerjee A; Bhowmik N; Patra M
    Mol Cell Biochem; 2012 Aug; 367(1-2):59-63. PubMed ID: 22547198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of differentially expressed proteins in human glioblastoma cell lines and tumors.
    Zhang R; Tremblay TL; McDermid A; Thibault P; Stanimirovic D
    Glia; 2003 Apr; 42(2):194-208. PubMed ID: 12655603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of non-supervised MALDI mass spectrometry imaging combined with microproteomics for glioma grade III classification.
    Le Rhun E; Duhamel M; Wisztorski M; Gimeno JP; Zairi F; Escande F; Reyns N; Kobeissy F; Maurage CA; Salzet M; Fournier I
    Biochim Biophys Acta Proteins Proteom; 2017 Jul; 1865(7):875-890. PubMed ID: 27890679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
    Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
    Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer proteomics: a review for clinicians.
    Galvão ER; Martins LM; Ibiapina JO; Andrade HM; Monte SJ
    J Cancer Res Clin Oncol; 2011 Jun; 137(6):915-25. PubMed ID: 21465318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioma pathophysiology: insights emerging from proteomics.
    Deighton RF; McGregor R; Kemp J; McCulloch J; Whittle IR
    Brain Pathol; 2010 Jul; 20(4):691-703. PubMed ID: 20175778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.